The use of cyclosporin in a child with generalized pustular psoriasis

SIR, There are various bullous diseases showing autoantibodies to the basement membrane zone (BMZ). Bullous pemphigoid (BP) sera react with the 230 kDa BP antigen (BP230) and/or the 180 kDa BP antigen (BP180). Epidermolysis bullosa acquisita (EBA) sera react with the 290 kDa EBA antigen (type VII collagen). The sera of cicatricial pemphigoid and linear IgA bullous dermatosis show heterogeneous reactivity. In addition, a 200 kDa antigen located in the deeper portion of the lamina lucida has been identified as a novel antigen in a patient with atypical bullous lesions, and patients with longstanding psoriasis associated with blister formation. We present two patients with vesicular pemphigoid-like clinical features, who showed anti-BMZ antibodies against the 200 kDa protein. Patient 1, a 64-year-old Japanese man, developed itchy erythematous skin lesions up to 1 cm in size, associated with crusts and erosions (Fig. 1). Only a few vesicles were seen. An annular arrangement of lesions was occasionally seen. He never developed large tense bullae characteristic of BP. This patient did not respond well to systemic steroids. However, the skin lesions quickly cleared, leaving slight scarring, after administration of dapsone, 100 mg daily. The dosage was tapered to 50 mg daily without recurrence. Patient 2, a 64-year-old Japanese man, developed vesicles and erosions up to 0·5 cm in size, over the entire body. The lesions on the palms and soles resembled palmoplantar pustulosis. Neither large tense bullae nor an annular arrangement of lesions was seen. This patient responded well to a combination of oral prednisolone, 40 mg daily and dapsone, 75 mg daily. This case was reported in a Japanese journal in 1982, without any results of antigen studies. In both cases, histopathological studies showed subepidermal bullae with infiltration predominantly of neutrophils. Direct immunofluorescence (IF) showed IgG and C3 deposition at the BMZ. On indirect IF of 1 mol/L NaCl-split skin, IgG in the sera reacted only with the dermal side of the split. On immunoblotting (IB) of normal human epidermal extracts, the sera did not react with either BP230 or BP180. On IB of recombinant protein of the BP180 NC16a domain, which is known to be recognized by almost all BP sera, the sera showed no reactivity. In contrast, on IB of human dermal extracts, the sera reacted exclusively with a 200 kDa protein, while control EBA sera reacted with the 290 kDa EBA antigen. The 200 kDa band showed exactly the same migration on the gel as in previously reported cases. The present two patients showed only small skin lesions, corresponding to vesicular pemphigoid, and the skin lesions were responsive to dapsone. Linear IgG deposition along the BMZ was detected by direct IF. However, in contrast to BP, the sera of these patients reacted with the dermal side of 1 mol/L NaCl-split skin on indirect IF. On IB of various antigen sources including normal epidermal extracts, dermal extracts and recombinant protein of the BP180 NC16a domain, these sera reacted only with a 200 kDa protein present in the dermal extracts, but not with any other known autoantigens. This 200 kDa antigen has been detected in a patient with atypical bullous lesions and in patients with psoriasis. This study indicates that a subset of patients with the vesicular pemphigoid phenotype may also react with this antigen, although the nature of this 200 kDa antigen has not been characterized.

[1]  Khorshid,et al.  Melanoma excision by general practitioners in North–East Thames region, England , 1998, The British journal of dermatology.

[2]  Varma,et al.  Pseudoporphyria caused by nabumetone , 1998, The British journal of dermatology.

[3]  H. Trau,et al.  Unusual skin ulceration in an HIV‐positive patient who had cutaneous syphilis and neurosyphilis , 1998, The British journal of dermatology.

[4]  G. Smith,et al.  Meta-analysis Spurious precision? Meta-analysis of observational studies , 1998, BMJ.

[5]  George Davey Smith,et al.  Meta-analysis: Principles and procedures , 1997, BMJ.

[6]  P. Bossuyt,et al.  A systematic review of five systemic treatments for severe psoriasis , 1997, The British journal of dermatology.

[7]  T. Bieber,et al.  A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. , 1997, The New England journal of medicine.

[8]  F. Arias,et al.  Acral erythema and intrahepatic 5‐fluorouracil infusion , 1997 .

[9]  M. Nahata,et al.  Oral Terbinafine: A New Antifungal Agent , 1997, The Annals of pharmacotherapy.

[10]  M. Pittelkow,et al.  Hydroxyurea dermopathy: a unique lichenoid eruption complicating long-term therapy with hydroxyurea. , 1997, Journal of the American Academy of Dermatology.

[11]  C. la Vecchia,et al.  Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. , 1996, British Journal of Cancer.

[12]  J. Weidner,et al.  Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients , 1996, The Journal of experimental medicine.

[13]  L Timmermann,et al.  The mechanism of action of cyclosporin A and FK506. , 1996, Clinical immunology and immunopathology.

[14]  W. Wilkinson,et al.  Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients , 1996, The Journal of experimental medicine.

[15]  J. Fijter,et al.  Isotretinoin and azathioprine: a synergy that makes hair curl? , 1996, The Lancet.

[16]  V. Ho,et al.  Treatment of pyoderma gangrenosum. , 1996, Journal of the American Academy of Dermatology.

[17]  D. Reid,et al.  Elevated nitric oxide production in rheumatoid arthritis. Detection using the fasting urinary nitrate:creatinine ratio. , 1996, Arthritis and rheumatism.

[18]  AJ McMichael,et al.  Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? , 1996, British Journal of Cancer.

[19]  P. Hartge,et al.  Non-Hodgkin's lymphoma and sunlight. , 1996, Journal of the National Cancer Institute.

[20]  A. Rawlings,et al.  Seasonal influences on stratum corneum ceramide 1 fatty acids and the influence of topical essential fatty acids , 1996, International journal of cosmetic science.

[21]  Y. Hirata,et al.  Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. , 1995, The Journal of clinical investigation.

[22]  L. Fielding,et al.  The association between melanoma, lymphoma, and other primary neoplasms. , 1995, Archives of surgery.

[23]  P. Hall,et al.  Non‐Hodgkin's lymphoma and skin malignancies‐shared etiology? , 1995, International journal of cancer.

[24]  H. Tagami,et al.  Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment , 1995, The British journal of dermatology.

[25]  A. Vladutiu,et al.  Role of nitric oxide in autoimmunity. , 1995, Clinical immunology and immunopathology.

[26]  G. Murrell,et al.  Nitric oxide activates metalloprotease enzymes in articular cartilage. , 1995, Biochemical and biophysical research communications.

[27]  A V Rawlings,et al.  Stratum corneum moisturization at the molecular level. , 1994, The Journal of investigative dermatology.

[28]  J. Brodehl Consensus statements on the optimal use of cyclosporine in pediatric patients. , 1994, Transplantation proceedings.

[29]  A. Staines,et al.  The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight. , 1994, Leukemia & lymphoma.

[30]  B. Nelson,et al.  Curly lusterless hair: anatomic surface changes on transplanted hair shafts. , 1993, The Journal of dermatologic surgery and oncology.

[31]  D. Margolis,et al.  Hydroxyurea and lower leg ulcers. , 1993, Cutis.

[32]  G. Papa,et al.  Multiple skin tumors on light-exposed areas during long-term treatment with hydroxyurea. , 1993, Journal of the American Academy of Dermatology.

[33]  S. Moncada,et al.  Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. , 1992, Annals of the rheumatic diseases.

[34]  J. Yarbro Mechanism of action of hydroxyurea. , 1992, Seminars in oncology.

[35]  L. Xerri,et al.  Lymphadenopathic tumor exhibiting intermingled features of Kaposi's sarcoma, malignant lymphoma, and angiofollicular hyperplasia. , 1991, Archives of pathology & laboratory medicine.

[36]  E. Christophers,et al.  Clearing of Pyoderma gangrenosum by intralesional cyclosporin A , 1991, The British journal of dermatology.

[37]  A. Ledo,et al.  Treatment of pyoderma gangrenosum with cyclosporin A , 1991, Clinical and experimental dermatology.

[38]  J. Baron,et al.  [Kaposi's sarcoma associated with chronic B lymphocytic leukemia. Coexistence of both diseases in skin lesions]. , 1991, Medicina clinica.

[39]  B. Baack,et al.  Chemotherapy-induced acral erythema. , 1991, Journal of the American Academy of Dermatology.

[40]  S. Muller,et al.  Generalized pustular psoriasis in childhood. Report of thirteen cases. , 1991, Journal of the American Academy of Dermatology.

[41]  H. Tagami,et al.  Exanthematic type of pustular psoriasis consisting of two types of pustular lesion. , 1991, Acta dermato-venereologica.

[42]  F. Truchetet,et al.  Skin lesions simulating chronic dermatomyositis during long-term hydroxyurea therapy. , 1989, Journal of the American Academy of Dermatology.

[43]  B. Forslind,et al.  Human hair form. Morphology revealed by light and scanning electron microscopy and computer aided three-dimensional reconstruction. , 1988, Archives of dermatology.

[44]  S. Neill,et al.  Keratoderma of myxoedema , 1988, Clinical and experimental dermatology.

[45]  G. Lucas,et al.  Painful red hands: a side‐effect of leukaemia therapy , 1988, The British journal of dermatology.

[46]  M. Meinardi,et al.  Generalized pustular psoriasis (von Zumbusch) responding to cyclosporin A , 1987, The British journal of dermatology.

[47]  G. Cox,et al.  Toxic erythema of palms and soles associated with high-dose mercaptopurine chemotherapy. , 1986, Archives of dermatology.

[48]  F. Suchy,et al.  Pustular pyoderma gangrenosum associated with ulcerative colitis in childhood. Report of two cases and review of the literature. , 1986, Journal of the American Academy of Dermatology.

[49]  C. Carcassi,et al.  A Case of Classical Kaposi's Sarcoma in B-Cell Chronic Lymphocytic Leukemia (B-CLL) , 1986, Tumori.

[50]  E. Hodak,et al.  Palmoplantar keratoderma in association with myxedema. , 1986, Acta dermato-venereologica.

[51]  F. Mandelli,et al.  Unusual Dermatologic Toxicity of Long-Term Therapy with Hydroxyurea in Chronic Myelogenous Leukemia , 1986, Tumori.

[52]  R. Stern,et al.  An evaluation of method reporting and use in clinical trials in dermatology. , 1985, Archives of dermatology.

[53]  G. Koren,et al.  Coexistence of Kaposi's sarcoma and chronic lymphocytic leukemia in the same lymph node. , 1985, Acta haematologica.

[54]  Callen Jp,et al.  Vesiculopustular eruption in a patient with ulcerative colitis. Pyoderma gangrenosum. , 1985, Archives of dermatology.

[55]  J. Lokich,et al.  Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome. , 1984, Annals of internal medicine.

[56]  J. Gern,et al.  Vesiculopustular eruption of ulcerative colitis. , 1983, Archives of dermatology.

[57]  L. Espinoza,et al.  Acral erythema and hydroxyurea. , 1983, Annals of internal medicine.

[58]  J. Jorizzo,et al.  Dermatologic conditions reported in patients with rheumatoid arthritis. , 1983, Journal of the American Academy of Dermatology.

[59]  F. Tanda,et al.  Primary Kaposi's sarcoma and Hodgkin's disease in the same lymph node. , 1982, American journal of clinical pathology.

[60]  T. Nagata,et al.  ATRICHIA WITH PAPULAR LESIONS ASSOCIATED WITH GASTROINTESTINAL POLYPOSIS , 1979, The Journal of dermatology.

[61]  Z. Weshler,et al.  Primary Kaposi's sarcoma in lymph nodes concurrent with chronic lymphatic leukemia. , 1979, American journal of clinical pathology.

[62]  H. Perry,et al.  A diffuse pustular eruption associated with ulcerative colitis. , 1978, Archives of dermatology.

[63]  G. Harding,et al.  VALPROATE AND CURLY HAIR , 1977, The Lancet.

[64]  H. Shaw,et al.  Multiple primary cancers in patients with malignant melanoma. , 1976, The Medical journal of Australia.

[65]  B. Kennedy,et al.  Skin changes secondary to hydroxyurea therapy. , 1975, Archives of dermatology.

[66]  A. Carnevale,et al.  ATRICHIA WITH PAPULAR LESIONS AND MENTAL RETARDATION IN TWO SISTERS , 1974, International journal of dermatology.

[67]  I. Penn,et al.  Cutaneous complications in immunosuppressed renal homograft recipients. , 1974, JAMA.

[68]  R. Freinkel,et al.  Hair growth and alopecia in hypothyroidism. , 1972, Archives of dermatology.

[69]  J. Prakken,et al.  Atrichia with papular lesions; a variant of congenital ectodermal dysplasia. , 1954, Dermatologica.

[70]  W. Shaw,et al.  Hypothyroidism, liver damage, and vitamin A deficiency as factors in hyperkeratosis. , 1952, A.M.A. archives of dermatology and syphilology.

[71]  Scully Jp Congenital ichthyosiform erythroderma. , 1950, A.M.A. archives of dermatology and syphilology.

[72]  H. Maibach,et al.  Topical FK506--clinical potential or laboratory curiosity? , 1994, Dermatology.

[73]  B. Piraccini,et al.  Atrichia and papular lesions: report of a case. , 1992, Dermatology.

[74]  K. Trott,et al.  Radiation Effects in Skin , 1991 .

[75]  A. Lorincz,et al.  Distinctive acral erythema occurring during therapy for severe myelogenous leukemia. , 1985, Archives of dermatology.

[76]  I. Hashimoto,et al.  Genetic counseling for skin diseases. A statistical analysis of 182 cases. , 1983, Dermatologica.

[77]  I. Sarkany,et al.  Severe palmar keratoderma in myxoedema. , 1977, Clinical and experimental dermatology.

[78]  G. Peterkin,et al.  Juvenile generalized pustular psoriasis. A report of five cases and a review of the literature. , 1972, Archives of dermatology.